Latest News
Eli Lilly gets EUA for new antibody 'cocktail', which may cut deaths by 70%
Eli Lilly has clinched Emergency Use Approval in the US for an antibody treatment 'cocktail' that may reduce the risk of hospitalisation and death in high-risk patients by as much as 70%.
Syncona upbeat on Autolus US public offering pricing
Healthcare investor Syncona said on Wednesday that its portfolio company Autolus Therapeutics has priced its underwritten public offering in the United States at $7. 00 per American depositary share (ADS).
Covid lockdowns cost retailers £22bn - BRC
The three national Covid-19 lockdowns have cost non-essential retailers a combined £22bn in lost sales, the British Retail Consortium said on Thursday, as it called on the Chancellor to do more to help the sector.
Sector movers: Homebuilders, Travel names sag
Homebuilders and Travel names dragged on the wider market in the middle of the week, amid profit-taking in the former and after the Transport Secretary defended tougher travel restrictions.
US close: Stocks end mixed as some tech plays lose favour
Wall Street stocks finished in a mixed state on Wednesday, amid a rotation out of technology stocks and some key inflation data.
Polypipe to buy magnetic filters provider ADEY for £210m
Polypipe has agreed to buy ADEY, a provider of magnetic filters and chemicals, from private equity firm LDC and other shareholders for £210m in cash, part of which will be funded through a share placing.
Thursday preview: US jobless claims, AstraZeneca in the spotlight
The economic calendar on Thursday will be exceedingly light with a reading on weekly US unemployment claims the only event that might easily move markets.
Europe close: Stocks slip as investors monitor US stimulus, vaccine news
European shares slipped on Wednesday as investors looked for direction on US stimulus measures and the pace of vaccine rollouts across the continent.
London close: Stocks turn weaker in afternoon trading
London stocks closed just below the waterline on Wednesday as investors sifted through results from the likes of Smurfit Kappa and Dunelm.
Broker tips: National Express, Dr Martens, Ocado
Analysts at Canaccord Genuity raised their target price on public transport provider National Express from 255. 0p to 330. 0p on Wednesday, stating it was "increasingly confident" that the firm's financial performance will "largely return to normal" in 2022.
Grant Shapps stands behind 10-year jail sentences for those lying at UK border
Transport Secretary Grant Shapps said on Wednesday that the 10-year jail sentence for those trying to conceal travel from a "red list" country at the UK border is "appropriate".
88 Energy announces AUD 12m fundraise
88 Energy proposed to raise up to AUD 12m (£6. 7m) before expenses on Wednesday, to fund the ongoing evaluation of prospectivity of its existing assets, and to pursue new opportunities in Alaska.
UK government to inject extra £3.5bn into cladding removal
The UK government will provide a further £3. 5bn to remove cladding in buildings in the wake of Grenfell Tower fire to "end the scandal".
Director dealings: CMC Markets director makes share sale
CMC Markets revealed on Wednesday that non-executive director Clare Salmon had disposed to 12,227 ordinary shares in the FTSE 250-listed online trading platform operator.
Unicorns globally now worth $1.7trn - Trading Platforms UK
The valuation of the 528 unicorns worldwide reached $1. 7trn as of January 2021, the latest data from Trading Platforms UK showed.
Wednesday broker round-up
Ocado Group: Berenberg reiterates buy with a target price of 2,925p.
AstraZeneca to invest in new Covid-19 vaccine production in Eastern Germany
AstraZeneca may partner with Germany's IDT Biologika to produce its Covid-19 vaccine in a bid to bolster supplies.
Cora Gold announces series of new discoveries
West Africa-focussed Cora Gold announced a series of new surface gold discoveries from satellite imagery and surface prospecting programmes at the Sanankoro Gold Project on the Yanfolila Gold Belt in southern Mali on Wednesday.
FTSE 250 movers: Dunelm rallies on interims, housebuilders fall
London’s FTSE 250 was down 0. 8% at 20,942. 11 in afternoon trade on Wednesday.
BioNTech starts Covid-19 vaccine production at new Marburg plant
BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.